Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03121417
Title Biomarker-Driven Phase 2 Study of Nivolumab in Advanced Metastatic Non-small Cell Lung Cancer
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University
Indications

lung non-small cell carcinoma

Therapies

Nivolumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Emory University Hospital Midtown Atlanta Georgia 30308 United States Details
Emory University/Winship Cancer Institute Atlanta Georgia 30322 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field